Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives

Cited by (999)

Items 701–800 of 999

1. Neurodegenerative Disease Transmission and Transgenesis in Mice
   Brittany N. Dugger, Daniel P. Perl, George A. Carlson · 2017 · Cold Spring Harbor Perspectives in Biology
2. New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer’s disease
   Christiane Rose, Katell Peoc’h, Stéphanie Chasseigneaux, Claire Paquet, Julien Dumurgier, Fanchon Bourasset, Frédéric Calon, Jean Laplanche, Jacques Hugon, Bernadette Allinquant · 2012 · BMC Neuroscience
3. Glucose uptake in PC12 cells: GLUT3 vesicle trafficking and fusion as revealed with a novel GLUT3‐GFP fusion protein
   M. Heather West Greenlee, Etsuro Uemura, Susan L. Carpenter · 2003 · Journal of Neuroscience Research
4. Biosynthesis and differential processing of two pools of amyloid‐β precursor protein in a physiologically inducible neuroendocrine cell
   Rob W.J. Collin, Helma van den Hurk, Gerard J.M. Martens · 2005 · Journal of Neurochemistry
5. Axonal and Neuronal Amyloid Precursor Protein Immunoreactivity in the Brains of Guinea Pigs Given Tunicamycin
   John W. Finnie, J. Manavis, P. Blumbergs, T. Kuchel · 2000 · Veterinary Pathology-Supplement
6. THE ARTERIAL CHEMORECEPTORS
   Yoshiaki Hayashida, Hisatake Kondo, Constancio González · 2006 · Advances in experimental medicine and biology
7. Glutamate Receptors in Aging and Alzheimer's Disease
   Amanda J. Mishizen-Eberz, Miloš D. Ikonomović, David M. Armstrong · 2001 · Elsevier eBooks
8. Expression of the gene encoding the β-amyloid precursor protein APP in Xenopus laevis
   Helma van den Hurk, Marjon Bloemen, Gerard J.M. Martens · 2001 · Molecular Brain Research
9. Remodelling of Ca2+ homeostasis in type I cortical astrocytes by hypoxia: evidence for association with Alzheimer's disease
   Chris Peers, Ian F. Smith, John P. Boyle, Hugh A. Pearson · 2004 · Biological Chemistry
10. Cytoprotective function of sAPPα in human keratinocytes
    Sven Wehner, Christina Siemes, Gregor Kirfel, Volker Herzog · 2004 · European Journal of Cell Biology
11. ■ REVIEW : The Presenilins
    Mark P. Mattson, Qing Guo · 1999 · The Neuroscientist
12. Amyloid Aß , cut from APP by ß-secretase BACE1 and γ-secretase, induces apoptosis via opening type-1 porin/VDAC in cell membranes of hypometabolic cells—A basic model for the induction of apoptosis!?
    Friedrich Peter THINNES · 2010 · Molecular Genetics and Metabolism
13. The signaling cascades of Ganoderma lucidum extracts in stimulating non-amyloidogenic protein secretion in human neuroblastoma SH-SY5Y cell lines
    Sirinthorn Pinweha, Payong Wanikiat, Yupin Sanvarinda, Porntip Supavilai · 2008 · Neuroscience Letters
14. Olfactory Deprivation Hastens Alzheimer-Like Pathologies in a Human Tau-Overexpressed Mouse Model via Activation of cdk5
    Ke Li, Fangfang Liu, Chun-Xue He, He‐Zhou Huang, Ao‐Ji Xie, Fan Hu, Dan Liu, Jian‐Zhi Wang, Ling‐Qiang Zhu · 2014 · Molecular Neurobiology
15. SNX8 Enhances Non-amyloidogenic APP Trafficking and Attenuates Aβ Accumulation and Memory Deficits in an AD Mouse
    Yongzhuang Xie, Mengxi Niu, Chengxiang Ji, Timothy Y. Huang, Cuilin Zhang, Ye Tian, Zhun Shi, Chen Wang, Yingjun Zhao, Hong Luo et al. · 2019 · Frontiers in Cellular Neuroscience
16. Molecular and cell biological aspects of Alzheimer disease
    B.S. Shastry · 2001 · Journal of Human Genetics
17. Secretion of Protease Nexin-II/Amyloid β Protein Precursor by Human Colorectal Carcinoma Cells and Its Modulation by Cytokines/Growth Factors and Proteinase Inhibitors
    Kohji Seguchi, Hiroaki Kataoka, Hirofumi Uchino · 1999 · Biological Chemistry
18. Cordycepin, a bioactive compound from Cordyceps spp ., moderates Alzheimer’s disease-associated pathology via anti-oxidative stress and autophagy activation
    Natchadaporn Sorraksa, Nudjanad Heebkaew, Wilasinee Promjantuek, Phongsakorn Kunhorm, Palakorn Kaokean, Nipha Chaicharoenaudomung, Parinya Noisa · 2023 · Journal of Asian Natural Products Research
19. Inhibition of hippocampal mossy fiber plasticity and episodic memory by human Aβ oligomers is prevented by enhancing cAMP signaling in Alzheimer's mice
    Shan‐Xue Jin, Jean‐Pierre Bellier, Adrienne R. Wells, Paula D.L.M. Montero Llopis, Praju Vikas Anekal, Jason S. Tresback, Barbara J. Caldarone, Lei Liu, Shaomin Li, Ulf Dettmer et al. · 2025 · Alzheimer s & Dementia
20. Plant-based vaccines for Alzheimer's disease: an overview
    Sergio Rosales‐Mendoza, Néstor Rubio‐Infante, Sergio Zarazúa, Dania O. Govea‐Alonso, Guadalupe Martel‐Gallegos, Leticia Moreno‐Fierros · 2014 · Expert Review of Vaccines
21. Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: The Case of Edaravone
    Cristina Agresti, Rosella Mechelli, Stefania Olla, Caterina Veroni, Cecilia Eleuteri, Giovanni Ristori, Marco Salvetti · 2019 · Current Medicinal Chemistry
22. A Natural Squamosamide Derivative FLZ Reduces Amyloid-β Production by Increasing Non-Amyloidogenic AβPP Processing
    Yan Hou, Young-Beob Yu, Geng-Tao Liu, Yuan Luo · 2009 · Journal of Alzheimer s Disease
23. Shortage of Lipid-radical Cycles in Membranes as a Possible Prime Cause of Energetic Failure in Aging and Alzheimer Disease
    L. F. Dmitriev · 2007 · Neurochemical Research
24. The mRNA of the NR1 subtype of glutamate receptor in Alzheimer's disease
    Peter K. Panegyres, Katina Toufexis, Byron A. Kakulas · 2002 · Journal of Neural Transmission
25. A novel antibody targeting sequence 31–35 in amyloid β protein attenuates Alzheimer's disease‐related neuronal damage
    Li Cheng, Jun Zhang, Xinyi Li, Yuan Li, Yanfang Pan, Xiaorong Chen, Tianming Gao, Jian‐Tian Qiao, Jin‐Shun Qi · 2016 · Hippocampus
26. Neuroprotective Strategies in Alzheimer’s Disease
    Christian Behl · 2003 · Advances in experimental medicine and biology
27. Differential expression of Bcl-2 and APP immunoreactivity after intrastriatal injection of MPP+ in the rat.
    J. Chuang, Shur Tzu Chen · 2002 · Neurochemistry International
28. Apolipoprotein E4 decreases whereas apolipoprotein E3 increases the level of secreted amyloid precursor protein after closed head injury.
    Y. Ezra, L. Oron, L. Moskovich, A. Roses, S. M. Beni, E. Shohami, Daniel M. Michaelson · 2003 · Neuroscience
29. α-Secretase-Derived Cleavage of Cellular Prion Yields Biologically Active Catabolites with Distinct Functions
    Marie‐Victoire Guillot‐Sestier, Frédéric Checler · 2012 · Neurodegenerative Diseases
30. Exploring the potential mechanism of ginsenoside Rg1 to regulate ferroptosis in Alzheimer's disease based on network pharmacology
    Xu Deng, Zixiong Qiu, Xiaoshuai Chen, Jiangxiu Liu, Xiaowei Wang, Jie Li, Jiankai Zhang, Xiaojun Cui, Yuan Fu, Mei Jiang · 2024 · European Journal of Pharmacology
31. Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach
    Florence Haut, Elentina K. Argyrousi, Ottavio Arancio · 2023 · International Journal of Molecular Sciences
32. LRP::FLAG Rescues Cells from Amyloid-β-Mediated Cytotoxicity Through Increased TERT Levels and Telomerase Activity
    Monique J. Bignoux, Katelyn Cuttler, Tyrone C. Otgaar, Eloise Ferreira, Boitelo T. Letsolo, Stefan F. T. Weiss · 2019 · Journal of Alzheimer s Disease
33. Unveiling the inhibitory mechanism of peptidomimetic inhibitor against Aβ42 aggregation and protofibril disaggregation by molecular dynamics
    Rajdeep Kaur, Rajneet Kaur Saini, Pritpal Singh, Bhupesh Goyal · 2021 · Journal of Molecular Liquids
34. Different effects of monocarboxylates on neuronal survival and β‐amyloid toxicity
    XiaoNan Wang, Toshihiro Takata, Takashi Sakurai, Koichi Yokono · 2007 · European Journal of Neuroscience
35. The processing and biological function of the human amyloid precursor protein (APP): lessons from different cellular models
    Pascal Kienlen‐Campard, Bernadette Tasiaux, Jean Noël Octave · 2000 · Experimental Gerontology
36. Aluminum does not enhance β-amyloid toxicity in rat hippocampal cultures
    Christiane M. Nday, Benjamin D. Drever, Thanos Salifoglou, Bettina Platt · 2010 · Brain Research
37. Métabolisme du précurseur du peptide amyloïde et présénilines
    Frédéric Checler, Cristine Alvès da Costa, Cécile Dumanchin‐Njock, Elvira Lopez‐Perez, Philippe Marambaud, Erwan Paitel, Agnès Petit-Paitel, Bruno Vincent · 2002 · médecine/sciences
38. Neuroprotective effect of D-fructose-1,6-bisphosphate against beta-amyloid induced neurotoxicity in rat hippocampal organotypic slice culture: involvement of PLC and MEK/ERK signaling pathways.
    Xiuzhen Song, Bin Wu, Toshihiro Takata · 2005 · PubMed
39. Human platelet calcium mobilisation in response to ß-amyloid (25–35): buffer dependency and unchanged response in Alzheimer’s disease
    Henrietta L.M. Hedin, Sture Eriksson, Christopher John Fowler · 2001 · Neurochemistry International
40. Neurodevelopmental disorders and microcephaly: how apoptosis, the cell cycle, tau and amyloid-β precursor protein APPly
    Deborah K. Sokol, Debomoy K. Lahiri · 2023 · Frontiers in Molecular Neuroscience
41. Amyloid Precursor Protein Changes Arrangement in a Membrane and Its Structure Depending on the Cholesterol Content
    Vladimir D. Krasnobaev, Yaroslav V. Bershatsky, Olga V. Bocharova, Eduard Valeryevich Bocharov, Oleg V. Batishchev · 2023 · Membranes
42. Molecular insights into the structure destabilization effects of ECG and EC on the Aβ protofilament: An all-atom molecular dynamics simulation study
    Rongzu Nie, Shan-shuo Zhang, Xiao-ke Yan, Kun Feng, Yan-jing Lao, Ya-ru Bao · 2023 · International Journal of Biological Macromolecules
43. LRP/LR specific antibody IgG1-iS18 impedes neurodegeneration in Alzheimer's disease mice
    Eloise Ferreira, Monique J. Bignoux, Tyrone C. Otgaar, Nicolas Tagliatti, Katarina Jovanovic, Boitelo T. Letsolo, Stefan F. T. Weiss · 2018 · Oncotarget
44. The Potential Effect of Fluorinated Compounds in the Treatment of Alzheimer’s Disease
    Bárbara Gomes, Joana A. Loureiro, Manuel A. N. Coelho, Maria do Carmo Pereira · 2015 · Current Pharmaceutical Design
45. Synthesis and evaluation of antineurotoxicity properties of an amyloid-β peptide targeting ligand containing a triamino acid
    Dmytro Honcharenko, Partha Pratim Bose, Jyotirmoy Maity, Firoz Roshan Kurudenkandy, Alok Juneja, Erik Flöistrup, Henrik Biverstål, Jan Johansson, Lennart Nilsson, André Fisahn et al. · 2014 · Organic & Biomolecular Chemistry
46. Données fondamentales sur les pathologies amyloïde et Tau dans la maladie d’Alzheimer : quelles perspectives thérapeutiques ?
    Frédéric Checler, Luc Buée · 2009 · Annales Pharmaceutiques Françaises
47. The Involvement of Lipid Radical Cycles and the Adenine Nucleotide Translocator in Neurodegenerative Diseases
    L. F. Dmitriev · 2007 · Journal of Alzheimer s Disease
48. Sphingomyelin and ceramide in brain aging, neuronal plasticity and neurodegenerative disorders
    Mark P. Mattson, R. G. Cutler · 2003 · Advances in cell aging and gerontology
49. Effects of an inhibitor of α-secretase, which metabolizes the amyloid peptide precursor, on memory formation in rats
    Nadezhda M. Dubrovskaya, Natalia N. Nalivaeva, Anthony J. Turner · 2006 · Neuroscience and Behavioral Physiology
50. Substrate-Specific Activation of α-Secretase by 7-Deoxy-Trans-Dihydronarciclasine Increases Non-Amyloidogenic Processing of β-Amyloid Protein Precursor
    Yoon Sun Chun, Yoon Young Cho, Oh-Hoon Kwon, Dong Feng Zhao, Hyun Ok Yang, Sungkwon Chung · 2020 · Molecules
51. Tuning the self-assembled nanostructures of ultra-short bola peptides via side chain variations of the hydrophobic amino acids
    Yurong Zhao, Xingfan Li, Limin Zhang, Dong Wang, Wenxin Wang, Li Wang, Cuixia Chen · 2020 · Journal of Molecular Liquids
52. Differential regulation of Cu, Zn- and Mn-superoxide dismutases by retinoic acid in normal and psoriatic human fibroblasts
    Pascale Gerbaud, Loïc Petzold, Patrice Thérond, Wayne B. Anderson, Danièle Evain‐Brion, Françoise Raynaud · 2004 · Journal of Autoimmunity
53. The Association of Aluminium and β Amyloid in Alzheimer’s Disease
    Christopher Exley, Olga V. Korchazhkina · 2001 · Elsevier eBooks
54. Factors controlling axonal and dendritic arbors
    CHARLES H. KEITH, Mark T. Wilson · 2001 · International review of cytology
55. Effects of bFGF and TGFβ on the expression of amyloid precursor and B-cell lymphoma protooncogene proteins in the rat retina
    S T. Chen, Angela Jen, Steve Gentleman · 1999 · Neuroreport
56. Evidence for binding of the ectodomain of amyloid precursor protein 695 and activated high molecular weight kininogen
    Arpita Das, Neil R. Smalheiser, Adam N. Markaryan, Arnold Kaplan · 2002 · Biochimica et Biophysica Acta (BBA) - General Subjects
57. Hexapeptides HLDF-6 and PEDF-6 restore memory in rats after chronic intracerebroventricular treatment with β-amyloid peptide Aβ(25–35)
    Zinaida I. Storozheva, Andrey T. Proshin, Sergey S Zhokhov · 2006 · Bulletin of Experimental Biology and Medicine
58. 2-Deoxyglucose induces β-APP overexpression, tau hyperphosphorylation and expansion of the trans-part of the Golgi complex in rat cerebral cortex
    Paweł Grieb, Wanda Gordon‐Krajcer, Małgorzata Frontczak‐Baniewicz, Michal Walski, M Ryba, Tomasz Kryczka, Michał Fiedorowicz, Piotr Kulinowski, Zenon Sułek, Katarzyna Majcher et al. · 2004 · Acta Neurobiologiae Experimentalis
59. Oxygen-induced DNA damage in freshly isolated brain cells compared with cultured astrocytes in the Comet assay
    Eduardo Cemeli, Ian F. Smith, Chris Peers · 2003 · Teratogenesis Carcinogenesis and Mutagenesis
60. Long-term exposition of cells to β-amyloid results in decreased intracellular calcium concentration
    András Palotás, Janos L. Kalman, Miklós Palotás, Lajos Vince Kemény, Zoltán Janka, Botond Penke · 2003 · Neurochemistry International
61. From Bench to Bedside: Unveiling the Effects of Phloroglucinol as a Promising Neuroprotective Agent in the Battle Against Neurodegenerative Disorders
    Nayana Bhuyan, Shatabdi Ghose, Nikhil Biswas, Jaheer Ali Sultan, Damiki Laloo · 2024 · Current Behavioral Neuroscience Reports
62. Platelets and Neurodegenerative Diseases
    Lili Donner, Margitta Elvers · 2017 · Springer eBooks
63. Red neurons in ovine polioencephalomalacia (cerebrocortical necrosis) are strongly amyloid precursor protein immunopositive
    John W Finnie, Ian V. Jerrett, Jim Manavis · 2022 · Veterinary Research Communications
64. Chapter 9 The Role of Mitochondrial Genome Mutations in Neurodegenerative Disease
    Gordon W. Glazner · 1999 · Advances in cell aging and gerontology
65. Role of Apoptosis in Age-Related Pathologies
    Владимир Габдуллович Зайнуллин, Alexey Moskalev · 2001 · Russian Journal of Developmental Biology
66. Retinoic acid-induced upregulation of the metalloendopeptidase nardilysin is accelerated by co-expression of the brain-specific protein p42IP4 (centaurin α1; ADAP1) in neuroblastoma cells
    Claudia Borrmann, Rolf Stricker, Georg Reiser · 2011 · Neurochemistry International
67. Relationship Between Amyloid Precursor Protein in Seminal Plasma and Abnormal Penile Sympathetic Skin Response in Lifelong Premature Ejaculation
    Zhiwei Hong, Yuming Feng, Hualong Ding, Xuechun Hu, Jin‐Chun Lu, Xie Ge, Yi‐Feng Ge, Bing Yao · 2017 · The Journal of Sexual Medicine
68. Nicotine Promotes AβPP Nonamyloidogenic Processing via RACK1-Dependent Activation of PKC in SH-SY5Y-AβPP695 Cells
    Wenting He, Man Tu, Yehong Du, Junjie Li, Yayan Pang, Zhifang Dong · 2020 · Journal of Alzheimer s Disease
69. Chapter 5 Metabolism of the Aging Brain
    John P. Blass, Gary E. Gibson, Siegfried Hoyer · 1997 · Advances in cell aging and gerontology
70. Activation of Programmed Cell Death by Calcium: Protection against Cell Death by the Calcium Binding Protein, Calbindin-D28k
    Sylvia Christakos, Frank Barletta, Michael Huening, Jody Kohut, Mihali Raval-Pandya · 2000 · Springer eBooks
71. Using In silico LD clumping and meta-analysis of genome-wide datasets as a complementary tool to investigate and validate new candidate biomarkers in Alzheimer's disease.
    Christopher Medway, Hui Shi, James M. Bullock, Holly A. Black, Kristelle S. Brown, Baharak Vafadar‐Isfahani, Balwir Matharoo‐Ball, Graham Ball, Robert C. Rees, Noor A Kalsheker et al. · 2010 · PubMed Central
72. Porcine APP cDNAs: Molecular cloning and characterization, expression analysis, chromosomal localization and SNP analysis
    Marianne Abildgaard Oerum, Christian Bendixen, Lone Bruhn Madsen · 2006 · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
73. Transfection of Human Neuroblastoma Cells with Alzheimer’s Disease Brain Hallmarks as a Promising Strategy to Investigate the Role of Neurosteroidogenesis in Neuroprotection
    Christine Patte‐Mensah, Laurence Meyer, Véronique Schaeffer, Anne Eckert, Ayikoe Guy Mensah‐Nyagan · 2012 · BioValley monographs
74. Polypeptide and Protein Aggregates with Neurotoxic Properties in Neurodegenerative Disorders: Emphasis on β-Amyloid-Induced Dysfunction of Receptor-Mediated Signal Transduction Pathways
    Yann Verdier, Botond Penke · 2006 · Current Signal Transduction Therapy
75. A Review of the Neurotrophic and Neuroprotective Properties of ONO‐1603: Comparison with Those of Tetrahydroaminoacridine, an Antidementia Drug
    Nobuo C. Katsube, Ryoichi Ishitani · 2000 · CNS Drug Reviews
76. The coding sequence of amyloid-β precursor protein APP contains a neural-specific promoter element
    Rob W.J. Collin, Gerard J.M. Martens · 2006 · Brain Research
77. Tuning supramolecular architectures of KI4K amphiphiles via varying terminal variations
    Yurong Zhao, Wei Bo Yang, Li Ping Deng, Dong Wang · 2017 · Journal of Molecular Liquids
78. The Protective Role of Vitamin E in Vascular Amyloid β-Mediated Damage
    Francisco J. Muñoz, Montserrat Solé, Mireia Coma · 2006 · Springer eBooks
79. Harnessing the potential of long non-coding RNAs in the pathophysiology of Alzheimer's disease
    Rasanpreet Kaur, Swadha Pandey, Saurabh Kumar Gupta, Jitendra Pratap Singh · 2024 · Experimental Neurology
80. Interaction of Sp1 and APP promoter elucidates a mechanism for Pb2+ caused neurodegeneration
    Qi Gao, Ziwen Dai, Shiqing Zhang, Yuqiang Fang, Ken Kin Lam Yung, Pik Kwan Lo, King Wai Chiu Lai · 2020 · Archives of Biochemistry and Biophysics
81. Patterns of cognitive decline and somatosensory processing in a mouse model of amyloid accumulation
    Olivia Uddin, Keiko Arakawa, Charles Raver, Brendon Garagusi, Asaf Keller · 2021 · Neurobiology of Pain
82. Improved NMDA Receptor Activation by the Secreted Amyloid-Protein Precursor-α in Healthy Aging: A Role for D-Serine?
    Jean‐Marie Billard, Thomas Fréret · 2022 · International Journal of Molecular Sciences
83. Mechanisms of Neuronal Apoptosis and Excitotoxicity
    Sana Mostafa · 2023 · Springer eBooks
84. The Association of Circulating Glucagon-Like Peptide-1 with Cognitive Functions and Biomarkers in Alzheimer’s Disease
    Mengqing Liu, Nenghong Ma, Xiao Jing Yang, Miao Sun, Xiaowen Li, Yu-Hui Liu, Qing Chang, Changchun Hei · 2024 · Journal of Alzheimer s Disease
85. Decreases in Plasma Aβ1-40 Levels with Aging in Non-Demented Elderly with ApoE-ε4 Allele
    Nunzio Pomara, Binbin Shao, Thomas Wısnıewskı, Pankaj D Mehta · 1998 · Neurochemical Research
86. Defects of Immune Regulation in the Presenilin-1 Mutant Knockin Mouse
    Grant A. Morgan, Qing Guo, Sic L. Chan · 2006 · NeuroMolecular Medicine
87. Effect of haloperidol and risperidone on amyloid precursor protein levels in vivo
    András Palotás, Magdolna Pákáski, Miklós Palotás, Marietta Hugyecz, József Molnár, Botond Penke, Zoltán Janka, Janos L. Kalman · 2003 · Brain Research Bulletin
88. Dopamine promotes cathepsin B-mediated amyloid precursor protein degradation by reactive oxygen species-sensitive mechanism in neuronal cell
    Sanju Kumari, A.K. Mukherjee, Chinmay K. Mukhopadhyay · 2018 · Molecular and Cellular Biochemistry
89. The Potential of Induced Pluripotent Stem Cells to Treat and Model Alzheimer’s Disease
    Joseph M. Schulz · 2021 · Stem Cells International
90. Antioxidant Activity of Bol D'Air Jacquier® Breathing Sessions in Wistar Rats — First Studies
    B. Mercier, Josiane Prost, Michel Prost · 2008 · International Journal of Occupational Medicine and Environmental Health
91. Insulin signaling in the aging nervous system
    Eduardo Melani Rocha, Maria Luiza Fernandes, Licio Augusto Velloso · 2004 · Advances in cell aging and gerontology
92. [38] Involvement of superoxide in pathogenic action of mutations that cause Alzheimer's disease
    Mark P. Mattson · 2002 · Methods in enzymology on CD-ROM/Methods in enzymology
93. APOE Polymorphisms and Late-Onset Alzheimer Disease
    Walter A. Kukull, George M. Martin · 1998 · JAMA
94. Effects of staurosporine, U-73122, wortmannin, 4-hydroxynonenal and sodium azide upon the release of secreted β-amyloid precursor protein from human platelets in response to thrombin stimulation
    Henrietta L.M. Hedin, Lisa M. Nilsson, Christopher James Fowler · 2001 · Molecular and Cellular Biochemistry
95. The role of amyloid beta 4-42 in the etiology of Alzheimer's disease
    Yvonne Bouter · 2015
96. Axonal degeneration in hemorrhagic stroke: A systematic review
    Amir Pasokh, Lamija Hadziavdic, Tracy D. Farr, Marietta Zille · 2025 · Pharmacological Research
97. Cognitive impairment in Diabetes Mellitus
    Ahmed Ragaa, Nermin Aly Hamdy, Michael Atef Fawzy, Noran Hamza, Zahraa Wally · 2023 · Journal of advanced Biomedical and Pharmaceutical Sciences
98. Exploring the Impact of C‐Terminal Based Pentapeptides on the Disassembly of Aβ42 Fibrils
    Apneet Kaur, Opinder Kaur Mankoo, Diksha Rani, Nitesh Priyadarshi, Deepti Goyal, Nitin Kumar Singhal, Bhupesh Goyal · 2024 · ChemMedChem
99. Bexarotene cannot reduce amyloid beta plaques through inhibition of production of amyloid beta peptides: in silico and in vitro study
    Pham Dinh Quoc Huy, Nguyen Quoc Thai, Zuzana Bednáriková, Huynh Quang Linh, Zuzana Gažová, Mai Suan Li · 2018 · Physical Chemistry Chemical Physics
100. Infrared spectroscopy and imaging for understanding neurodegenerative protein-misfolding diseases
     Lisa M. Miller · 2020 · Elsevier eBooks